| Primary |
| Hormone Replacement Therapy |
75.6% |
| Menopausal Symptoms |
8.2% |
| Oestrogen Replacement Therapy |
4.1% |
| Menopause |
3.2% |
| Hot Flush |
2.5% |
| Hypertension |
1.0% |
| Drug Use For Unknown Indication |
0.7% |
| Prophylaxis |
0.7% |
| Osteoporosis |
0.7% |
| Depression |
0.5% |
| Night Sweats |
0.4% |
| Vulvovaginal Dryness |
0.3% |
| Anxiety |
0.3% |
| Hormone Therapy |
0.3% |
| Product Used For Unknown Indication |
0.3% |
| Diabetes Mellitus |
0.2% |
| Osteoporosis Prophylaxis |
0.2% |
| Blood Cholesterol Increased |
0.2% |
| Cardiac Disorder |
0.2% |
| Hypothyroidism |
0.2% |
|
| Breast Cancer |
63.9% |
| Breast Cancer Metastatic |
17.3% |
| Breast Cancer Female |
4.2% |
| Thrombosis |
1.5% |
| Cerebrovascular Accident |
1.4% |
| Contralateral Breast Cancer |
1.3% |
| Pulmonary Embolism |
1.2% |
| Ovarian Cancer |
1.0% |
| Breast Cancer In Situ |
1.0% |
| Progesterone Receptor Assay Positive |
1.0% |
| Drug Ineffective |
1.0% |
| Breast Cancer Recurrent |
1.0% |
| Myocardial Infarction |
0.9% |
| Deep Vein Thrombosis |
0.8% |
| Ovarian Cancer Metastatic |
0.7% |
| Weight Increased |
0.5% |
| Vaginal Haemorrhage |
0.4% |
| Hot Flush |
0.4% |
| Metastases To Lymph Nodes |
0.3% |
| Metrorrhagia |
0.3% |
|
| Secondary |
| Hormone Replacement Therapy |
74.9% |
| Menopausal Symptoms |
7.0% |
| Menopause |
5.9% |
| Hypertension |
2.1% |
| Hot Flush |
1.6% |
| Depression |
1.3% |
| Hormone Therapy |
0.7% |
| Osteoporosis |
0.7% |
| Blood Cholesterol Increased |
0.6% |
| Hypothyroidism |
0.6% |
| Anxiety |
0.5% |
| Night Sweats |
0.5% |
| Blood Pressure |
0.5% |
| Vulvovaginal Dryness |
0.5% |
| Thyroid Disorder |
0.5% |
| Pain |
0.4% |
| Arthritis |
0.4% |
| Gastrooesophageal Reflux Disease |
0.4% |
| Cardiac Disorder |
0.4% |
| Drug Use For Unknown Indication |
0.4% |
|
| Breast Cancer Female |
58.3% |
| Breast Cancer |
25.9% |
| Breast Cancer Metastatic |
3.2% |
| Ovarian Cancer |
1.9% |
| Progesterone Receptor Assay Positive |
1.8% |
| Breast Cancer In Situ |
1.5% |
| Drug Ineffective |
1.4% |
| Cerebrovascular Accident |
0.8% |
| Thrombosis |
0.8% |
| Pulmonary Embolism |
0.6% |
| Deep Vein Thrombosis |
0.5% |
| Uterine Leiomyoma |
0.5% |
| Vaginal Haemorrhage |
0.5% |
| Weight Increased |
0.4% |
| Vomiting |
0.4% |
| Ovarian Cancer Metastatic |
0.4% |
| Myocardial Infarction |
0.3% |
| Invasive Ductal Breast Carcinoma |
0.3% |
| Pain |
0.3% |
| Hot Flush |
0.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
15.5% |
| Osteoporosis |
12.9% |
| Osteopenia |
7.8% |
| Rheumatoid Arthritis |
7.1% |
| Hypertension |
6.8% |
| Depression |
5.5% |
| Hormone Replacement Therapy |
5.3% |
| Drug Use For Unknown Indication |
5.1% |
| Pain |
5.0% |
| Gastrooesophageal Reflux Disease |
3.9% |
| Menopause |
3.0% |
| Anxiety |
3.0% |
| Arthritis |
2.8% |
| Blood Cholesterol Increased |
2.6% |
| Smoking Cessation Therapy |
2.6% |
| Asthma |
2.4% |
| Multiple Sclerosis |
2.3% |
| Hypersensitivity |
2.3% |
| Osteoarthritis |
2.2% |
| Hypothyroidism |
2.2% |
|
| Vomiting |
12.8% |
| Weight Decreased |
12.8% |
| Weight Increased |
12.5% |
| Nausea |
6.3% |
| Vision Blurred |
5.8% |
| Drug Ineffective |
5.3% |
| Urinary Tract Infection |
5.1% |
| Tremor |
4.6% |
| Myocardial Infarction |
3.7% |
| Headache |
3.4% |
| Hypertension |
3.1% |
| Pain |
3.1% |
| Pruritus |
3.0% |
| Rash |
3.0% |
| Injection Site Pain |
2.7% |
| Wound Dehiscence |
2.7% |
| Pain In Extremity |
2.6% |
| Pulmonary Embolism |
2.6% |
| Type 2 Diabetes Mellitus |
2.6% |
| Transient Ischaemic Attack |
2.4% |
|
| Interacting |
| Hormone Replacement Therapy |
25.0% |
| Hypertension |
25.0% |
| Menopause |
25.0% |
| Smoking Cessation Therapy |
25.0% |
|
| Hot Flush |
33.3% |
| Swollen Tongue |
33.3% |
| Syncope |
33.3% |
|
